Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04034030 · ClinicalTrials.gov registry record · NA

Repeated Oscillatory TMS Therapy of the Epileptogenic Cortical Area in Children With Focal CSWS

A NA study of CSWS, sponsored by Children's Mercy Hospital Kansas City.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04034030 is a NA study of CSWS that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04034030, a NA study of CSWS, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The investigators are investigating the effectiveness of a wearable multisite transcranial magnetic stimulation (mTMS) device that can deliver stimuli at multiple cortical sites simultaneously or sequentially for the treatment of an epileptic syndrome - focal continuous-spike and wave during sleep.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

Kansas

  • Children's Mercy Hospital - Overland Park

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-08-01
Est. Completion 2026-07-31
Phase NA

What the Registry Record Tells You About NCT04034030

The ClinicalTrials.gov registry entry for NCT04034030 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with CSWS appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT04034030 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT04034030 about?

NCT04034030 is a clinical study titled "Repeated Oscillatory TMS Therapy of the Epileptogenic Cortical Area in Children With Focal CSWS". The investigators are investigating the effectiveness of a wearable multisite transcranial magnetic stimulation (mTMS) device that can deliver stimuli at multiple cortical sites simultaneously or sequentially for the treatment of an epileptic syndrome - focal continuous-spike and wave during sleep.

What is the current status of trial NCT04034030?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-08-01. Estimated completion is 2026-07-31.

What conditions does trial NCT04034030 study?

This clinical trial studies the following conditions: CSWS.

What interventions are being tested in trial NCT04034030?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04034030?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04034030 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.